@4040rec.bsky.social
@pharmaphorum.bsky.socialPatients in #England and #Wales with #raredisease #familialchylomicronaemiasyndrome (FCS) will soon have a new treatment option, after #Sobi's #Tryngolza was recommended for #NHS use by #NICE.
@newsen.bsky.socialSwedish Orphan Biovitrum AB Sees Share Count Increase in 2026 #Sweden #Stockholm #Sobi #Swedish_Orphan_Biovitrum #class_C_shares
@newsen.bsky.socialKey Changes in Share Count and Voting Power at Swedish Orphan Biovitrum AB #Sweden #Stockholm #biotechnology #Sobi #Swedish_Orphan_Biovitrum
@newsen.bsky.socialNew Clinical Insights on Gamifant® to Be Unveiled at Histiocyte Society 2026 in Rotterdam #Netherlands #Sobi #Rotterdam #Gamifant #HLH
@newsen.bsky.socialSobi and Innate Pharma Launch Strategic Partnership for CTCL Drug Development #Sweden #Stockholm #Sobi #Lacutamab #Innate_Pharma